These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28210454)

  • 1. Managing patients taking edoxaban in dentistry.
    Curto A; Curto D; Sanchez J
    J Clin Exp Dent; 2017 Feb; 9(2):e308-e311. PubMed ID: 28210454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of apixaban for dental treatments.
    Curto A; Albaladejo A
    J Clin Exp Dent; 2016 Dec; 8(5):e611-e614. PubMed ID: 27957279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.
    Curto A; Albaladejo A; Alvarado A
    J Clin Exp Dent; 2017 Feb; 9(2):e289-e293. PubMed ID: 28210451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New oral anticoagulants and their implications for dental patients.
    O'Connell JE; Stassen LF
    J Ir Dent Assoc; 2014; 60(3):137-43. PubMed ID: 25080640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.
    Kustos SA; Fasinu PS
    Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31618893
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
    PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: An overview and analysis of novel oral anticoagulants and their dental implications.
    Fortier K; Shroff D; Reebye UN
    Gerodontology; 2018 Jun; 35(2):78-86. PubMed ID: 29493031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
    Hirschl M; Kundi M
    Vasa; 2014 Sep; 43(5):353-64. PubMed ID: 25147012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
    Lee SR; Choi EK; Kwon S; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
    Stroke; 2019 Aug; 50(8):2245-2249. PubMed ID: 31208303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications.
    Costantinides F; Rizzo R; Pascazio L; Maglione M
    BMC Oral Health; 2016 Jan; 16():5. PubMed ID: 26822674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.
    Bai Y; Shi XB; Ma CS; Lip GYH
    Am J Cardiol; 2017 Nov; 120(9):1689-1695. PubMed ID: 28844510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
    Kido K; Scalese MJ
    Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative to oral dicoumarin anticoagulants: Considerations in dental care.
    Mingarro-de-León A; Chaveli-López B
    J Clin Exp Dent; 2013 Dec; 5(5):e273-8. PubMed ID: 24455094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function.
    Hernandez I; Smith KJ; Zhang Y
    Thromb Res; 2017 Feb; 150():123-130. PubMed ID: 27771008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.
    Ageno W; Büller HR; Falanga A; Hacke W; Hendriks J; Lobban T; Merino J; Milojevic IS; Moya F; van der Worp HB; Randall G; Tsioufis K; Verhamme P; Camm AJ
    Thromb Haemost; 2016 Nov; 116(6):1003-1010. PubMed ID: 27488232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
    Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K
    J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.